Author

J. P. Becker

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. B. Riemer· 1 shared A. E. Kulozik· 1 shared A. Hernandez-Sanchez· 1 shared C. Lotsch· 1 shared D. Helm· 1 shared D. Jager· 1 shared F. Momburg· 1 shared F. Stein· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. B. Riemer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

optiPRM: A targeted immunopeptidomics LC-MS workflow with ultra-high sensitivity for the detection of mutation-derived tumor neoepitopes from limited input material

M. Salek, J. D. Forster, J. P. Becker, M. Meyer, P. Charoentong, Y. Lyu, K. Lindner, C. Lotsch, M. Volkmar, F. Momburg, I. Poschke, S. Frohling, M. Schmitz, R. Offringa, M. Platten, , A. B. Riemer

The paper introduces optiPRM, a targeted LC-MS workflow that enhances sensitivity for detecting mutation-derived neoepitopes from limited tumor samples.

Molecular & Cellular Proteomics · Sep 1, 2024Peer-reviewedImmunology

Pharmacological inhibition of nonsense-mediated RNA decay augments HLA class I-mediated presentation of neoepitopes in MSI CRC

J. P. Becker, D. Helm, M. Rettel, F. Stein, A. Hernandez-Sanchez, K. Urban, J. Gebert, M. Kloor, G. Neu-Yilik, M. von Knebel Doeberitz, M. W. Hentze, A. E. Kulozik

The paper shows that inhibiting nonsense-mediated RNA decay increases HLA class I presentation of neoepitopes from frameshift mutations in MSI colorectal cancer.

bioRxiv · Oct 13, 2020Cancer Biology